An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-16-0096
Full Text
Open PDFAbstract
Available in full text
Date
May 18, 2016
Authors
Publisher
American Association for Cancer Research (AACR)